Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.

@article{Kruis1997DoubleblindCO,
  title={Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.},
  author={Wolfgang Kruis and Ekkehard Sch{\"u}tz and Pruemysl Fric and Bohumil Fixa and Gerd Judmaier and Manfred Stolte},
  journal={Alimentary pharmacology & therapeutics},
  year={1997},
  volume={11 5},
  pages={853-8}
}
BACKGROUND Aminosalicylates are used as standard treatment for maintaining remission in ulcerative colitis. As yet, there is no other existing alternative with proven efficacy. In light of the hypothesis that the intestinal environment may contribute to the pathophysiology of ulcerative colitis, a trial was conducted to test the effects of probiotic treatment with an oral preparation of non-pathogenic E. coli. METHODS A total of 120 patients with inactive ulcerative colitis were included in a… CONTINUE READING

From This Paper

Topics from this paper.
197 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 197 extracted citations

Similar Papers

Loading similar papers…